sodium glycerophosphate pentahydrate

Trade name: Glycophos

Small moleculeapproved

Approved

Aug 25, 2014

Synthetic glycerophosphates have been known for many years and have been prepared in several ways. The acid may exist in two isomeric forms, alpha and beta. The L-a-acid is the naturally occurring form; the b-acid, present in hydrolyzates of lecithins from natural sources, arises from migration of the phosphoryl group from the a-carbon atom. Dehydrogenation of L-glycerol 3-phosphate produces Dihydroxyacetone phosphate and is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. — NCATS

Clinical trial activity

5 trials · 7 clinical orgs · 1 marketing orgs

Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Apr 30, 2008 (NCT01264588)

Timeline

2010s

  1. Aug 25, 2014

    Fresenius — Earliest FDA Approval

  2. Aug 25, 2014

    Fresenius — NDA Secondary Org

  3. Aug 25, 2014

    Fresenius — NDA Organization

2020s

  1. Jan 1, 2025

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Combination products

Approval history

  • approvedAug 25, 2014

Chemistry & pharmacology

Loading structure…

SMILES

O=P(O)(O)OCC([O-])C[O-].[Na+].[Na+]
Mol. weight
216.04 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Parenteral
Availability
Prescription Only

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • 1,2,3-propanetriol, mono(dihydrogen phosphate), disodium salt, hydrate
  • 1,2,3-propanetriol, mono(dihydrogen phosphate), disodium salt, hydrate
  • 1-phosphoglycerol
  • alpha-glycerophosphate
  • alpha-glycerophosphoric acid
  • alpha-glycerophosphoric acid, 1,2,3-propanetriol-1-(18)o,3-(dihydrogen phosphate)-labeled
  • alpha-glycerophosphoric acid, 1,2,3-propanetriol-2-(18)o,3-(dihydrogen phosphate)-labeled
  • alpha-glycerophosphoric acid, calcium salt
  • alpha-glycerophosphoric acid, disodium salt
  • alpha-glycerophosphoric acid, disodium salt hexahydrate(+-)-isomer
  • alpha-glycerophosphoric acid, disodium salt (+-)-isomer
  • alpha-glycerophosphoric acid, (dl)-isomer
  • alpha-glycerophosphoric acid, fe(+3) salt (3:2)
  • alpha-glycerophosphoric acid, fe salt
  • alpha-glycerophosphoric acid, monocalcium salt
  • alpha-glycerophosphoric acid, monocalcium salt (s)-isomer
  • alpha-glycerophosphoric acid, monomagnesium salt
  • alpha-glycerophosphoric acid, (r)-isomer
  • alpha-glycerophosphoric acid, (s)-isomer
  • alpha-glycerophosphoric acid, sodium salt
  • disodium glycerophosphate
  • glycerol 1-phosphate
  • glycerol 3-phosphate
  • glycerol phosphate disodium salt hydrate
  • glycerophosphate
  • glycerophosphate
  • glycerophosphate disodium salt hydrate
  • glycerophosphate disodium salt hydrate
  • glycerophosphoric acid
  • glycerophosphoric acid
  • glycophos
  • sodium glycerophosphate
  • sodium glycerophosphate
  • sodium glycerophosphate
  • sodium glycerophosphate
  • sodium glycerophosphate
  • sodium glycerophosphate
  • sodium glycerophosphate anhydrous
  • sodium glycerophosphate hydrate
  • sodium glycerophosphate hydrate
  • sodium glycerophosphate pentahydrate
  • sodium glycerophosphate pentahydrate
  • sodium glycerophosphate pentahydrate
  • sodium glycerophosphate pentahydrate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06842121Phase 1Jan 27, 2025Baxalta
NCT06842134Phase 1Jan 27, 2025Baxalta
NCT07060859N/AJan 15, 2023Al Azhar University
NCT05682846N/AMay 1, 2022Alexandria University
NCT01264588N/AApr 30, 2008AkPharma Inc., Cyberderm Inc., Texas Tech University, Thomas Jefferson University
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
BaxaltaFor profit2212025
AkPharma Inc.For profit1112008
Al Azhar UniversityAcademic/Hospital1112023
Alexandria UniversityAcademic/Hospital1112022
Cyberderm Inc.For profit1012008
Texas Tech UniversityAcademic/Hospital1012008
Thomas Jefferson UniversityAcademic/Hospital1012008
7 organizations
Page 1 / 1

Marketing (2)

OrganizationOrg typeRelationshipDate
FreseniusFor profitNDA2Aug 25, 2014
FreseniusFor profitNDAAug 25, 2014